Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Equity (2016 - 2025)

Collegium Pharmaceutical has reported Return on Equity over the past 10 years, most recently at 0.22% for Q4 2025.

  • Quarterly results put Return on Equity at 0.22% for Q4 2025, down 8.0% from a year ago — trailing twelve months through Dec 2025 was 0.22% (down 8.0% YoY), and the annual figure for FY2025 was 0.24%, down 9.0%.
  • Return on Equity for Q4 2025 was 0.22% at Collegium Pharmaceutical, down from 0.23% in the prior quarter.
  • Over the last five years, Return on Equity for COLL hit a ceiling of 0.5% in Q2 2021 and a floor of 0.22% in Q3 2022.
  • Median Return on Equity over the past 5 years was 0.22% (2025), compared with a mean of 0.18%.
  • Biggest five-year swings in Return on Equity: plummeted -68bps in 2022 and later surged 60bps in 2024.
  • Collegium Pharmaceutical's Return on Equity stood at 0.32% in 2021, then plummeted by -140bps to 0.13% in 2022, then surged by 302bps to 0.26% in 2023, then increased by 16bps to 0.3% in 2024, then dropped by -27bps to 0.22% in 2025.
  • The last three reported values for Return on Equity were 0.22% (Q4 2025), 0.23% (Q3 2025), and 0.16% (Q2 2025) per Business Quant data.